"Sotalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
| Descriptor ID |
D013015
|
| MeSH Number(s) |
D02.033.100.291.805 D02.092.063.291.805
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sotalol".
Below are MeSH descriptors whose meaning is more specific than "Sotalol".
This graph shows the total number of publications written about "Sotalol" by people in this website by year, and whether "Sotalol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sotalol" by people in Profiles.
-
Arrhythmias in Pregnancy. JACC Clin Electrophysiol. 2022 01; 8(1):120-135.
-
Inhibition of Human Ether-A-Go-Go-Related Gene (hERG) Potassium Current by the Novel Sotalol Analogue, Soestalol. JACC Clin Electrophysiol. 2020 07; 6(7):756-759.
-
Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2020 Feb; 41(2):418-422.
-
Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60.
-
Gender differences in cardiac repolarization following intravenous sotalol administration. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):86-92.
-
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
-
Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72.
-
The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007; 108(1):18-27.
-
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. J Am Coll Cardiol. 1998 Jul; 32(1):169-76.
-
The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.